Search results for: 'd21c access control'

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

This study covers U.S. markets for venous access devices including peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports, and catheter securement devices. This combination of new technology and expanding patient population will drive venous access catheters into significant growth th...

Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

The rise in both global population and travel is contributing to the increase in spread of infectious diseases. Rapid and accurate identification of the infectious pathogens are imperative for timely intervention, better patient outcomes, and control and management of the spread of the infection. Conventional infectious disease diagnoses are perfor...

Research shows that environmental surfaces in healthcare settings play a crucial role in pathogen transmission, leading to healthcare-acquired infections (HAIs), which have a considerable cost burden. Outpatient settings also pose significant infection risks. In the United States, millions of patients frequent outpatient facilities such as ambulato...

According to the World Health Organization, at least half of the world’s population do not have access to essential health services due to the high healthcare costs. Frugal medical device innovations can improve the healthcare accessibility and quality of care to the people, especially those at lower socio-economic status. This research service (RS...

In the rapidly evolving landscape of 2025, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

In the rapidly evolving landscape of 2026, where technological advancements are accelerating, the ability to identify, invest in, and leverage these advancements is becoming increasingly critical for organizations aiming to maintain industry leadership and ensure sustainable growth. Recognizing this imperative, Frost & Sullivan introduces (launches...

As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...